Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
about
Ultrasensitive Detection and Quantification of Toxins for Optimized Diagnosis of Clostridium difficile InfectionRisk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic reviewClinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 StrainsNosocomial transmission of C. difficile in English hospitals from patients with symptomatic infectionThe complexity and diversity of the Pathogenicity Locus in Clostridium difficile clade 5Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortalityDerivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection.Evolutionary clade affects resistance of Clostridium difficile spores to Cold Atmospheric Plasma.Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance.Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013Epidemic Clostridium difficile strains demonstrate increased competitive fitness compared to nonepidemic isolatesIntestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections.Evolutionary history of the Clostridium difficile pathogenicity locusStrategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.The LexA regulated genes of the Clostridium difficile.Phenotypic and genotypic analysis of Clostridium difficile isolates: a single-center study.Surface-layer protein A (SlpA) is a major contributor to host-cell adherence of Clostridium difficile.Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota.New role for human α-defensin 5 in the fight against hypervirulent Clostridium difficile strainsBroad coverage of genetically diverse strains of Clostridium difficile by actoxumab and bezlotoxumab predicted by in vitro neutralization and epitope modeling.Clostridium difficile PCR Ribotype 018, a Successful Epidemic GenotypeRisk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients.Changes in Colonic Bile Acid Composition following Fecal Microbiota Transplantation Are Sufficient to Control Clostridium difficile Germination and Growth.Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection.Genomic Epidemiology of a Protracted Hospital Outbreak Caused by a Toxin A-Negative Clostridium difficile Sublineage PCR Ribotype 017 Strain in London, EnglandSurface layer proteins from virulent Clostridium difficile ribotypes exhibit signatures of positive selection with consequences for innate immune responseNAP1 strain type predicts outcomes from Clostridium difficile infection.In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era.Comparison of Clostridium difficile Ribotypes Circulating in Australian Hospitals and Communities.Community-acquired Clostridium difficile infection: an increasing public health threat.Whole genome sequences of three Clade 3 Clostridium difficile strains carrying binary toxin genes in ChinaTherapy of Clostridium difficile infection: perspectives on a changing paradigm.Molecular methods in the diagnosis of Clostridium difficile infections: an update.Control of Clostridium difficile infection in the hospital setting.Antibodies for treatment of Clostridium difficile infection.Clostridium difficile spores: a major threat to the hospital environment.Description and validation of a new automated surveillance system for Clostridium difficile in Denmark.Clostridium difficile infection: epidemiology, diagnosis and understanding transmission.Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis.
P2860
Q26776411-25990662-0580-48BC-9A80-12C1C3F469AAQ27021390-B8C36992-96BF-493C-97A0-540CC9B8CE9AQ28354123-D9A14811-70DC-43AF-81A2-EEC793227222Q28658118-22EFE24F-BE97-4FA0-BFB5-E26837BA6ECAQ28830191-BF5F34F1-D205-4B53-B52E-7F51FDC6C7B9Q30413111-BED13303-C438-4EAB-92AA-D5BD114627E2Q30542192-D3FE23E5-6BFF-4F9F-A112-BF68107D888AQ33469737-1E34EA2A-A7F8-4F2D-80F2-8405B1B34473Q33728296-4785AAA6-BC42-4F53-87E3-3D819270D6A7Q33798369-E2DD52AD-E27E-422B-B3C5-98C04925D074Q33899721-72EBB99F-1666-4C49-9738-4E6032EA1FF7Q33903892-3AEDC394-B35D-415D-AB36-22CCABE55FD2Q34391822-5BED1116-B25A-4FA7-97A2-DAD542335F2DQ34419009-B8483691-8927-4CCA-855B-2CE679A1E468Q34524117-06D4971C-3172-4683-BAA5-5E75F9A72995Q35036237-3A1D1CEB-F10C-451C-86CC-E0486AF43933Q35050290-CEF7A6EB-4DCF-486A-9DAA-3565D63AA56CQ35091728-0B88130A-F17C-4232-B851-873E02E6B6A0Q35098190-076FA022-2649-4D48-84DE-C73881ABDDD2Q35106011-CD379149-E160-4DBB-8273-BB2DBD593594Q35652292-8044F533-9D4E-4019-9A1A-E6C6DE7151ABQ35860076-1AA5176E-2160-4D24-8737-68AC7A555D99Q35899010-EF2A9C86-34FC-4A62-B19F-05FCF7C7C6CCQ35930922-5F6F89EA-1C6C-4620-BA55-ADC89722219BQ36066807-B893844F-F8D2-4A82-9051-D19556E095F5Q36320846-9F417F36-5906-4A5A-B085-12C0767CEB27Q36420815-8C383FCC-7C82-478C-936E-FF6843086169Q36455915-4DEC9D8E-3B51-4909-93E2-708FF3110BA1Q37103258-C7E6DE22-C7F8-45A2-A588-5CBA621EF7FDQ37581870-D0C45510-44F0-4C0F-A0F5-9BE8EB873DA8Q37655456-7E34FCF2-FE36-4FD1-9AF1-1D30187B03E2Q37681661-8C039933-30EA-43A4-B96B-52452379D683Q38139991-C74D5162-DD48-40CA-A05D-B0A8D6E777A9Q38142247-CB1F029F-50C9-4BF1-8C1C-FDF1C6CFC2D4Q38192010-42917329-A429-4B9C-AC00-56CFEFAC51CDQ38208794-B573FDFB-7019-42C6-95AA-81D6E30788B8Q38210321-607FFB3C-9B34-461B-A54F-9162DD27A8B2Q38687899-7B15E7C5-BE12-4ABB-A560-B8F237C98B60Q38765888-5CCFB1A5-6AED-499E-88C0-20BAF4F21920Q38880576-7820E5DD-6D33-4F73-A902-56657393D5F0
P2860
Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Relationship between bacterial ...... ostridium difficile infection.
@ast
Relationship between bacterial ...... ostridium difficile infection.
@en
Relationship between bacterial ...... ostridium difficile infection.
@en-gb
type
label
Relationship between bacterial ...... ostridium difficile infection.
@ast
Relationship between bacterial ...... ostridium difficile infection.
@en
Relationship between bacterial ...... ostridium difficile infection.
@en-gb
prefLabel
Relationship between bacterial ...... ostridium difficile infection.
@ast
Relationship between bacterial ...... ostridium difficile infection.
@en
Relationship between bacterial ...... ostridium difficile infection.
@en-gb
P2093
P2860
P50
P356
P1154
2-s2.0-84877306933
P1476
Relationship between bacterial ...... ostridium difficile infection.
@en
P2093
A Sarah Walker
Alison Vaughan
Brian Shine
David Griffiths
David H Wyllie
Derrick W Crook
Infections in Oxfordshire Research Database
John Finney
Lily O'Connor
Sarah Oakley
P2860
P304
P356
10.1093/CID/CIT127
P407
P5530
P577
2013-03-05T00:00:00Z
P5875
P6179
1006786851